Vaccine developers unite to stand with scienceNine CEOs of COVID-19 vaccines have assured that safety of vaccinated individuals remains their top priority in development of the first COVID-19 vaccines. more ➔
Scope Fluidics gets EIB loan for infection diagnosticsThe European Investment Bank has lend up to €10m to Polish microbial diagnostics specialist Scope Fluidics AS. more ➔
COVID-19: Roche AG launches antigen rapid testRoche has announced to launch a SARS-CoV-2 point-of-care antigen test this month co-developed with SD Biosensor Inc. (South Korea). more ➔
Unilever to replace fossil carbon in cleaning productsUnilever has announced to invest €1bn globally to eliminate fossil fuels as a source of carbon in its cleaning products by 2030. more ➔
Stakeholders push for further pull incentivesWith around 450 attendees, the five-day digital conference particularly focused on market conditions and financing. SMEs and global partners urged for more pull incentives. more ➔
Bioversys bags €17.7m financingSwiss BioVersys AG has secured a CHF19m Series B financing to push clinincal development of two antiinfectives against drug-resistant pathogens. more ➔
Sotio licences Unum Therapeutics’ CAR-T cell portfolioPPF-owned company SOTIO has acquired the rights to use the BOXR CAR-T platform and products from Cambridge-based Unum Therapeutics. more ➔
Polyphor partners with Fosun Pharma Polyphor AG has licenced its metastatic cancer drug balixafortide to Fosun Pharma Co Ltd to market the drug exclusively in China. more ➔
Engitix Ltd. lands US$500m deal with Takeda in fibrosisBritish fibrosis therapeutics start-up Engitix Ltd has entered a collaboration agreement with Takeda to develop anti-fibrotic therapies in liver diseases. more ➔
Moderna set to deliver COVID-19 jab to the EUUS experiemental mRNA vaccine maker Moderna Inc is in advanced talks with the European Commission to supply 80 million doses mRNA-1273, its candidate vs SARS-CoV-2 more ➔
